The following chemical substances are listed in the 14th Report on Carcinogens, 2016, released by the National Institute of Environmental Health Sciences (NIEHS) under the National Toxicology Program (NTP) (Ref. 1); or in the World Health Organization's International Research on Cancer (IARC) Monographs on the Identification of Carcinogenic Hazards to Humans (Volumes 1-124) (Ref. 2); or in both.
Substances are grouped in two classes as defined in the NTP report:
OR
there is sufficient evidence of carcinogenicity from studies in experimental animals, which indicates there is an increased incidence of malignant and/or a combination of malignant and benign tumors (1) in multiple species or at multiple tissue sites, or (2) by multiple routes of exposure, or (3) to an unusual degree with regard to incidence, site, or type of tumor, or age at onset,
OR
there is less than sufficient evidence of carcinogenicity in humans or laboratory animals; however, the agent, substance, or mixture belongs to a well-defined, structurally related class of substances whose members are listed in a previous Report on Carcinogens as either known to be a human carcinogen or reasonably anticipated to be a human carcinogen, or there is convincing relevant information that the agent acts through mechanisms indicating it would likely cause cancer in humans.
Conclusions regarding carcinogenicity in humans or experimental animals are based on scientific judgment, with consideration given to all relevant information. Relevant information includes, but is not limited to, dose response, route of exposure, chemical structure, metabolism, pharmacokinetics, sensitive sub-populations, genetic effects, or other data relating to mechanism of action or factors that may be unique to a given substance. For example, there may be substances for which there is evidence of carcinogenicity in laboratory animals, but there are compelling data indicating that the agent acts through mechanisms which do not operate in humans and would therefore not reasonably be anticipated to cause cancer in humans.
IARC classifies substances as:
If there is inadequate evidence regarding carcinogenicity in humans, there should be strong evidence in human cells or tissues that the agent exhibits key characteristics of carcinogens. If there is limited evidence of carcinogenicity in humans, then the second individual evaluation may be from experimental systems (i.e., sufficient evidence of carcinogenicity in experimental animals or strong evidence in experimental systems that the agent exhibits key characteristics of carcinogens).
Only substances classified by IARC as Groups 1 and 2A are included in this list.
The NTP report and IARC monographs also list many poorly defined materials such as soots, tars, mineral oils, and coke oven emissions, as well as viruses, sunlight, ionizing radiation, etc. These substances are not included here.
Additional substances are evaluated by NTP on an ongoing basis but are not added to the list below until issued in its next formal report. See details in Ref. 1.
The table is ordered by the substance name normally used in the CRC Handbook. In many cases the primary name given here is different from that used in the NTP report and/or the IARC monographs; however, names used in the NTP report and/or the IARC monographs appear in the Synonym or Comments columns. Additional information and acronyms for the compounds are given in the Comments column. The substances classified by NTP as known carcinogens and those classified by IARC as Class 1 Carcinogenic to Humans are listed first.
Extensive details on each substance and of the classification approaches are given in the references.
Name | Synonym | Mol. form. | CAS Reg. No. | Comments | NTP Classification | IARC Classification |
Continued on next page... | ||||||
NTP Known to Be Human Carcinogens and/or IARC Group 1 | ||||||
Aflatoxins | 1402-68-2 | Known to be human carcinogens | Group 1 | |||
4-Aminobiphenyl | p-Biphenylamine | C12H11N | 92-67-1 | Known to be human carcinogens | Group 1 | |
Aristolochic acids | Known to be human carcinogens | Group 1 | ||||
Arsenic | As | 7440-38-2 | and inorganic arsenic compounds | Known to be human carcinogens | Group 1 | |
Asbestos | 1332-21-4 | IARC: all forms, including actinolite, amosite, anthophyllite, chrysotile, crocidolite, tremolite) | Known to be human carcinogens | Group 1 | ||
Azathioprine | 6-[(1-Methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-purine | C9H7N7O2S | 446-86-6 | Known to be human carcinogens | Group 1 | |
Benzene | [6]Annulene | C6H6 | 71-43-2 | Known to be human carcinogens | Group 1 | |
p-Benzidine | [1,1'-Biphenyl]-4,4'-diamine | C12H12N2 | 92-87-5 | includes dyes metabolized to benzidene | Known to be human carcinogens | Group 1 |
Benzo[a]pyrene | 2,3-Benzopyrene | C20H12 | 50-32-8 | Reasonably anticipated to be human carcinogens | Group 1 | |
Beryllium | Glucinium | Be | 7440-41-7 | and beryllium compounds | Known to be human carcinogens | Group 1 |
Bis(2-chloroethyl) sulfide | Mustard gas | C4H8Cl2S | 505-60-2 | listed by NTP as mustard gas; listed by IARC as sulfur mustard | Known to be human carcinogens | Group 1 |
Bis(chloromethyl) ether | Chloromethyl ether | C2H4Cl2O | 542-88-1 | and technical grade chloromethyl methyl ether | Known to be human carcinogens | Group 1 |
1,3-Butadiene | Divinyl | C4H6 | 106-99-0 | Known to be human carcinogens | Group 1 | |
1,4-Butanediol dimethylsulfonate | Busulfan | C6H14O6S2 | 55-98-1 | Reasonably anticipated to be human carcinogens | Group 1 | |
Cadmium | Cd | 7440-43-9 | and cadmium compounds | Known to be human carcinogens | Group 1 | |
Chlorambucil | C14H19Cl2NO2 | 305-03-3 | Known to be human carcinogens | Group 1 | ||
Chloroethene | Vinyl chloride | C2H3Cl | 75-01-4 | Known to be human carcinogens | Group 1 | |
1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea | Semustine | C10H18ClN3O2 | 13909-09-6 | also known as MeCCNU | Known to be human carcinogens | Group 1 |
Chloromethyl methyl ether | C2H5ClO | 107-30-2 | Known to be human carcinogens | Group 1 |